Cite

HARVARD Citation

    Kim, S. et al. (2016). Efficacy and safety of fixed-dose combination of olmesartan medoxomil and rosuvastatin in Korean patients with hypertension and dyslipidemia. Atherosclerosis. pp. e57-. [Online]. 
  
Back to record